A New Treatment For Parkinson's Disease Is Awaiting Final FDA Approval

www.myparkinsonsinfo.com
Main Category: Parkinson's Disease
Article Date: 08 May 2007 - 12:00 PDT

One of the most promising new drug therapies for the treatment of Parkinson's disease is a new dopamine agonist (a drug that mimics the action of dopamine in the brain). Unlike other dopamine agonists, this new drug is is delivered via a delivery system that enables blood levels of the drug to stay consistent throughout the day. Consistent blood levels are important because blood levels that are too high can lead to side effects such as uncontrolled movements and blood levels that are too low may not adequately control the symptoms of Parkinson's disease.

Studies have suggested that this new Parkinson's therapy may have properties that not only lessen parkinsonian symptoms, but may also protect nerve cells in the substania nigra from degeneration and death.

Clinical trials have been completed for this new Parkinson's therapy and it is currently awaiting FDA approval in the United States for the treatment of the symptoms of early Parkinson's disease.